Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C

Journal of Refractive Surgery

Volumn 27, Issue 7, 2011, Pages 530-541

  Chen, Shi Hao ^a   Feng, Yi Fan ^a   Stojanovic, Aleksandar ^b,c   Wang, Qin Mei ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b SynsLaser Kirurgi AS   (Norway)

^c SynsLaser Kirurgi AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ABLATION THERAPY; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; COMPARATIVE STUDY; CORNEAL ENDOTHELIAL CELL LOSS; EMBASE; EYE REFRACTION; GENETIC HETEROGENEITY; HUMAN; INTRAOPERATIVE PERIOD; LASER EPITHELIAL KERATOMILEUSIS; MEDLINE; META ANALYSIS; MYOPIA; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VISUAL ACUITY;

ALKYLATING AGENTS; CORNEA; CORNEAL TOPOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATECTOMY, SUBEPITHELIAL, LASER-ASSISTED; MITOMYCIN; MYOPIA; OPHTHALMIC SOLUTIONS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 79960813049     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20110112-02     Document Type: Review

References (67)

1. Guell J, Muller A. Laser in situ keratomileusis (LASIK) for myopia from -7 to -18 diopters. J Refract Surg. 1996;12(2):222-228. (Pubitemid 26089668)
2. Gimbel H, Penno E, van Westenbrugge JA, Ferensowicz M, Furlong MT. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases. Ophthalmology. 1998;105(10):1839-1847.
3. Pallikaris IG, Katsanevaki VJ, Panagopoulou SI. Laser in situ keratomileusis intraoperative complications using one type of microkeratome. Ophthalmology. 2002;109(1):57-63. (Pubitemid 34027424)
4. Pallikaris IG, Kymionis GD, Astyrakakis NI. Corneal ectasia induced by laser in situ keratomileusis. J Cataract Refract Surg. 2001;27(11):1796-1802. (Pubitemid 33055551)
5. Ambrosio R Jr, Wilson S. Complications of laser in situ keratomileusis: etiology, prevention, and treatment. J Refract Surg. 2001;17(3):350-379. (Pubitemid 32487873)
6. Taneri S, Feit R, Azar DT. Safety, efficacy and stability indices of LASEK correction in moderate myopia and astigmatism. J Cataract Refract Surg. 2004;30(10):2130-2137. (Pubitemid 39330671)
7. Vinciguerra P, Camesasca FI, Randazzo A. One-year results of butterfly laser epithelial keratomileusis. J Refract Surg. 2003;19(2 Suppl):S223-S226.
8. Partal AE, Rojas MC, Manche EE. Analysis of the efficacy, predictability and safety of LASEK for myopia and myopic astigmatism using the Technolas 217 excimer laser. J Cataract Refract Surg. 2004;30(10):2138-2144. (Pubitemid 39330672)
9. Kuo IC, Lee SM, Hwang DG. Late-onset corneal haze and myopic regression after photorefractive keratectomy (PRK). Cornea. 2004;23(4):350-355. (Pubitemid 38544050)
10. Trattler WB, Barnes SD. Current trends in advanced surface ablation. Curr Opin Ophthalmol. 2008;19(4):330-334.
11. Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 1991;109(8):1141-1146.
12. Majmudar PA, Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, Epstein RJ. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107(1):89-94. (Pubitemid 30210188)
13. Chalita MR, Roth A, Krueger RR. Wavefront-guided surface ablation with prophylactic use of mitomycin C after a buttonhole laser in situ keratomileusis flap. J Refract Surg. 2004;20(2):176-181. (Pubitemid 38375299)
14. Calabresi P, Chabner BA. Antineoplastic agents. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990:1247-1248.
15. Kim TI, Tchah H, Lee SA, Sung K, Cho BJ, Kook MS. Apoptosis in keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci. 2003;44(5):1912-1917. (Pubitemid 36522777)
16. Wallau AD, Campos M. One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK. Br J Ophthalmol. 2009;93(12):1634-1638.
17. Wallau AD, Campos M. Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. J Refract Surg. 2008;24(4):326-336. (Pubitemid 351543997)
18. de Benito-Llopis L, Teus MA, Sánchez-Pina JM. Comparison between LASEK with mitomycin C and LASIK for the correction of myopia of -7.00 to -13.75 D. J Refract Surg. 2008;24(5):516-523. (Pubitemid 351668880)
19. Seiler T, Wollensak J. Myopic photorefractive keratectomy with the excimer laser. One-year follow-up. Ophthalmology. 1991;98(8):1156-1163.
20. Leccisotti A. Mitomycin C in photorefractive keratectomy effect on epithelialization and predictability. Cornea. 2008;27(3):288-291. (Pubitemid 351440860)
21. Morales AJ, Zadok D, Mora-Retana R, Martínez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol. 2006;142(3):400-404. (Pubitemid 44691754)
22. Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L, Nassiri N. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg. 2008;34(6):902-908. (Pubitemid 351695506)
23. Waring GO III. Standard graphs for reporting refractive surgery. J Refract Surg. 2000;16(4):459-466. Erratum in J Refract Surg. 2001;17(3):following table of contents.
24. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. (Pubitemid 26120810)
25. Argento C, Cosentino MJ, Ganly M. Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. J Refract Surg. 2006;22(8):782-786. (Pubitemid 44595123)
26. Bedei A, Marabotti A, Giannecchini I, Ferretti C, Montagnani M, Martinucci C, Barabesi L. Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C: 1-year results. Eur J Ophthalmol. 2006;16(2):229-234. (Pubitemid 43874392)
27. Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg. 2002;28(12):2088-2095. (Pubitemid 36026085)
28. Gambato C, Ghirlando A, Moretto E, Busato F, Midena E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005;112(2):208-219.
29. de Benito-Llopis L, Teus MA, Ortega M. Effect of mitomycin C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg. 2007;33(6):1009-1013. (Pubitemid 46771079)
30. Nakano EM, Bains HS, Hirai FE, Portellinha W, Oliveira M, Nakano K. Comparison of laser epithelial keratomileusis with and without mitomycin C for wavefront customized surface ablations. J Refract Surg. 2007;23(9 Suppl):S1021-S1028. (Pubitemid 350175102)
31. Kim ST, Koh JW, Yoon GJ, Yang SW. Clinical outcomes of epi- LASIK: 1-year results of on- and off-flap procedures with and without mitomycin-C. Br J Ophthalmol. 2010;94(5):592-596.
32. de Benito-Llopis L, Teus MA, Sánchez-Pina JM, Fuentes I. Stability of LASEK with and without mitomycin-C performed to correct myopia in thin corneas: a 15-month follow-up. Am J Ophthalmol. 2008;145(5):807-812.
33. Leccisotti A. Mitomycin-C in hyperopic photorefractive keratectomy. J Cataract Refract Surg. 2009;35(4):682-687.
34. Thornton I, Puri A, Xu M, Krueger RR. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol. 2007;144(5):673-681.
35. Rajan MS, O'Brart DPS, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J Cataract Refract Surg. 2006;32(10):1741-1747. (Pubitemid 44436844)
36. Chen WL, Chang HW, Hu FR. In vivo confocal microscopic evaluation of corneal wound healing after epi-LASIK. Invest Ophthalmol Vis Sci. 2008;49(6):2416-2423.
37. Midena E, Gambato C, Miotto S, Cortese M, Salvi R, Ghirlando A. Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study. J Refract Surg. 2007;23(9 Suppl): S1011-S1014. (Pubitemid 350175100)
38. Camellin M. Laser epithelial keratomileusis with mitomycin C: indications and limits. J Refract Surg. 2004;20(5 Suppl):S693-S698. (Pubitemid 39299520)
39. Lee DH, Chung HS, Jeon YC, Boo SD, Yoon YD, Kim JG. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg. 2005;31(12):2293-2298. (Pubitemid 43212917)
40. Thornton I, Xu M, Krueger RR. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. J Refract Surg. 2008;24(1):S68-S76.
41. Virasch VV, Majmudar PA, Epstein RJ, Vaidya NS, Dennis RF. Reduced application time for prophylactic mitomycin C in photorefractive keratectomy. Ophthalmology. 2010;117(5):885-889.
42. Zhao LQ, Wei RL, Ma XY, Zhu H. Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2008;34(10):1715-1719.
43. Rajan MS, Watters W, Patmore A, Marshall J. In vitro human corneal model to investigate stromal epithelial interactions following refractive surgery. J Cataract Refract Surg. 2005;31(9):1789-1801. (Pubitemid 41503439)
44. Randleman JB, Loft ES, Banning CS, Lynn MJ, Stulting RD. Outcomes of wavefront optimized surface ablation. Ophthalmology. 2007;114(5):983-988. (Pubitemid 46635841)
45. Moller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Stromal wound healing explains refractive instability and haze development after photorefractive keratectomy: a 1-year confocal microscopic study. Ophthalmology. 2000;107(7):1235-1245.
46. Dupps WJ, Wilson SE. Biomechanics and wound healing in the cornea. Exp Eye Res. 2006;83(4):709-720. (Pubitemid 44292672)
47. Rajan MS, Jaycock P, O'Brart D, Nystrom HH, Marshall J. A long-term study of photorefractive keratectomy: 12-year follow-up. Ophthalmology. 2004;111(10):1813-1824. (Pubitemid 39311831)
48. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp Eye Res. 2004;78(3):553-560. (Pubitemid 38183334)
49. Lin N, Yee SB, Mitra S, Chuang AZ, Yee RW. Prediction of corneal haze using an ablation depth/corneal thickness ratio after laser epithelial keratomileusis. J Refract Surg. 2004;20(6):797-802. (Pubitemid 39546368)
50. Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg. 2006;22(6):562-574.
51. Lacayo GO III, Majmudar PA. How and when to use mitomycin- C in refractive surgery. Curr Opin Ophthalmol. 2005;16(4):256-259. (Pubitemid 41073310)
52. Barnes SD. Why does the army persist with PRK in a LASIK world? In: ASCRS Summer Refractive Surgery Conference Abstracts. Fairfax, VA: American Society of Cataract and Refractive Surgery; 2006.
53. Aydin B, Cagil N, Erdogan S, Erdurmus M, Hasiripi H. Effectiveness of laser-assisted subepithelial keratectomy without mitomycin-C for the treatment of high myopia. J Cataract Refract Surg. 2008;34(8):1280-1287. (Pubitemid 352024372)
54. Stojanovic A, Nitter TA. Correlation between ultraviolet radiation level and the incidence of late-onset corneal haze after photorefractive keratectomy. J Cataract Refract Surg. 2001;27(3):404-410. (Pubitemid 32233839)
55. Stojanovic A, Ringvold A, Nitter T. Ascorbate prophylaxis for corneal haze after photorefractive keratectomy. J Refract Surg. 2003;19(3):338-343. (Pubitemid 36605373)
56. Esquenazi S, He J, Bazan NG, Bazan HE. Comparison of corneal wound-healing response in photorefractive keratectomy and laser-assisted subepithelial keratectomy. J Cataract Refract Surg. 2005;31(8):1632-1639. (Pubitemid 41208046)
57. Azar DT, Ang RT, Lee JB, Kato T, Chen CC, Jain S, Gabison E, Abad JC. Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy. Curr Opin Ophthalmol. 2001;12(4):323-328. (Pubitemid 32751692)
58. Lee JB, Javier JA, Chang JH, Chen CC, Kato T, Azar DT. Confocal and electron microscopic studies of laser subepithelial keratomileusis (LASEK) in the white leghorn chick eye. Arch Ophthalmol. 2002;120(12):1700-1706. (Pubitemid 36401806)
59. Vinciguerra P, Azzolini M, Radice P, Sborgia M, De Molfetta V. A method for examining surface and interface irregularities after photorefractive keratectomy and laser in situ keratomileusis: predictor of optical and functional outcomes. J Refract Surg. 1998;14(2 Suppl):S204-S206. (Pubitemid 28193635)
60. Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res. 2006;82(5):788-797. (Pubitemid 43170879)
61. Torres RM, Merayo-Lloves J, Daya SM, Blanco-Mezquita JT, Espinosa M, Nozal MJ, Bernal JL, Bernal J. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg. 2006;32(1):67-71. (Pubitemid 43330051)
62. Song JS, Kim JH, Yang M, Sul D, Kim HM. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration. Cornea. 2006;25(10 Suppl):S20-S23.
63. Song JS, Kim JH, Yang M, Sul D, Kim HM. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application: effects of mitomycin-C application time and concentration. Cornea. 2007;26(4):461-467. (Pubitemid 46684388)
64. Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, Edelhauser HF. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg. 2007;23(7):724-727. (Pubitemid 47424681)
65. Pérez-Santonja JJ, Sahla HF, Alió JL. Evaluation of endothelial cell changes 1 year after excimer laser in situ keratomileusis. Arch Ophthalmol. 1997;115(7):841-846. (Pubitemid 27299155)
66. Wiffen SJ, Hodge DO, Bourne WM. The effect of contact lens wear on the central and peripheral corneal endothelium. Cornea. 2000;19(1):47-51. (Pubitemid 30007744)
67. Isager P, Hjortdal JO, Ehlers N. Magnification changes in specular microscopy after corneal refractive surgery. Acta Ophthalmol Scand. 1999;77(4):391-393. (Pubitemid 29368851)